Search research articles
Contact Us
Filters
Showing results (191-200 of 374) with videos related to
Page
of 38
Sort By:
Transplantation and Cellular Therapy
|
August 5, 2024
Allogeneic Hematopoietic Cell Transplantation for Myelofibrosis Aged 70 Years or Older: A Study from the German Registry for Stem Cell Transplantation
Nico Gagelmann, Claudia Schuh, Robert Zeiser, et al.
British Journal of Haematology
|
July 30, 2025
The importance of systemic inflammatory response measurements as pretransplant risk factors for outcome after allogeneic haematopoietic cell transplantation
Hartmut Bertz, Jörg Sahlmann, Donald C McMillan, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
July 5, 2021
Development of an integrated model of care for allogeneic stem cell transplantation facilitated by eHealth-the SMILe study
Lynn Leppla, Anja Schmid, Sabine Valenta, et al.
European Journal of Haematology
|
October 12, 2023
Identification of clinical factors impacting outcome in patients undergoing autologous hematopoietic cell transplantation after BEAM and TEAM conditioning
Radu-Florian Gherman, Sophie Ewald, Gabriele Ihorst, et al.
Blood Advances
|
October 5, 2021
The impact of pulmonary function in patients undergoing autologous stem cell transplantation
Jesús Duque-Afonso, Sophie Ewald, Gabriele Ihorst, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 8, 2014
Silencing of the EPHB3 tumor-suppressor gene in human colorectal cancer through decommissioning of a transcriptional enhancer
Sabine Jägle, Kerstin Rönsch, Sylvia Timme, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 6, 2015
A Novel Function for P2Y2 in Myeloid Recipient-Derived Cells during Graft-versus-Host Disease
Verena Klämbt, Sebastian A Wohlfeil, Lukas Schwab, et al.
Circulation
|
April 9, 2015
MicroRNA-155 Exerts Cell-Specific Antiangiogenic but Proarteriogenic Effects During Adaptive Neovascularization
Franziska Pankratz, Xavier Bemtgen, Robert Zeiser, et al.
Annals of Hematology
|
March 30, 2026
Donor lymphocyte infusions for recurrence of myeloid neoplasms after allogeneic hematopoietic cell transplantation in the era of hypomethylating agents and BCL2 inhibitors
Miriam Mozaffari Jovein, Thomas Meyer, Miguel Waterhouse, et al.
Molecular Cancer Research : MCR
|
June 5, 2021
Oncogenic <i>Kras</i> Activation in the Nonhematopoietic Bone Marrow Microenvironment Causes Myelodysplastic Syndrome in Mice
Lena Osswald, Shaima'a Hamarsheh, Franziska Maria Uhl, et al.
Page
of 38
Search research articles
Search
Showing results (191-200 of 374) with videos related to
Sort By:
Page
of 38
Transplantation and Cellular Therapy
|
August 5, 2024
Allogeneic Hematopoietic Cell Transplantation for Myelofibrosis Aged 70 Years or Older: A Study from the German Registry for Stem Cell Transplantation
Nico Gagelmann, Claudia Schuh, Robert Zeiser, et al.
British Journal of Haematology
|
July 30, 2025
The importance of systemic inflammatory response measurements as pretransplant risk factors for outcome after allogeneic haematopoietic cell transplantation
Hartmut Bertz, Jörg Sahlmann, Donald C McMillan, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
July 5, 2021
Development of an integrated model of care for allogeneic stem cell transplantation facilitated by eHealth-the SMILe study
Lynn Leppla, Anja Schmid, Sabine Valenta, et al.
European Journal of Haematology
|
October 12, 2023
Identification of clinical factors impacting outcome in patients undergoing autologous hematopoietic cell transplantation after BEAM and TEAM conditioning
Radu-Florian Gherman, Sophie Ewald, Gabriele Ihorst, et al.
Blood Advances
|
October 5, 2021
The impact of pulmonary function in patients undergoing autologous stem cell transplantation
Jesús Duque-Afonso, Sophie Ewald, Gabriele Ihorst, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 8, 2014
Silencing of the EPHB3 tumor-suppressor gene in human colorectal cancer through decommissioning of a transcriptional enhancer
Sabine Jägle, Kerstin Rönsch, Sylvia Timme, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 6, 2015
A Novel Function for P2Y2 in Myeloid Recipient-Derived Cells during Graft-versus-Host Disease
Verena Klämbt, Sebastian A Wohlfeil, Lukas Schwab, et al.
Circulation
|
April 9, 2015
MicroRNA-155 Exerts Cell-Specific Antiangiogenic but Proarteriogenic Effects During Adaptive Neovascularization
Franziska Pankratz, Xavier Bemtgen, Robert Zeiser, et al.
Annals of Hematology
|
March 30, 2026
Donor lymphocyte infusions for recurrence of myeloid neoplasms after allogeneic hematopoietic cell transplantation in the era of hypomethylating agents and BCL2 inhibitors
Miriam Mozaffari Jovein, Thomas Meyer, Miguel Waterhouse, et al.
Molecular Cancer Research : MCR
|
June 5, 2021
Oncogenic <i>Kras</i> Activation in the Nonhematopoietic Bone Marrow Microenvironment Causes Myelodysplastic Syndrome in Mice
Lena Osswald, Shaima'a Hamarsheh, Franziska Maria Uhl, et al.
Page
of 38